PathAI, a Boston, MA-based provider of AI-powered pathology platform has raised $60M in Series B funding led by General Atlantic with strong participation from General Catalyst and other existing investors. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors.Advanced Learning Towards Faster More Accurate Diagnosis of DiseaseCo-founded by Chief Executive Officer Dr. Andy Beck in 2016 with the mission to offer faster, safer and more powerful solutions
Read More
Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform
Digital pathology startup Deep Lens lands $14M in Series A funding to scale AI-driven digital pathology platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis has raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The funding comes months after Deep Lens emerged
Read More
Mount Sinai Researchers Develop AI Platform to Detect Neurodegenerative Diseases
Mount Sinai researchers have developed an artificial intelligence platform to detect a range of neurodegenerative disease in human brain tissue samples, including Alzheimer’s disease and chronic traumatic encephalopathy, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published in the Nature medical journal Laboratory Investigation. Their discovery will help scientists develop targeted biomarkers and therapeutics, resulting in a more accurate diagnosis of
Read More
Dosis Expands AI-Powered Strategic Anemia Advisor to 50 Clinics
Dosis, a San Francisco, CA-based developer of the Strategic Anemia Advisor (SAA) decision support tool, announced today that it has expanded its AI-powered personalized dosing platform to support to 50 dialysis clinics and 5,000 patients across the country. More than 550,000 End-Stage Renal Disease (ESRD) patients in the U.S. are currently undergoing dialysis treatment across the country, and the vast majority of those patients experience chronic anemia that requires dosing
Read More
NarrativeDx Raises $3M for Patient Experience Intelligence Platform
NarrativeDx, an Austin, TX-based artificial intelligence (AI) company that provides actionable insights from patient and provider feedback, today announced it has raised $3 million in strategic funding led by Christiana Care Health System, Summation Health Ventures and The Texas Medical Center. Also joining the round are HealthX Ventures and Cultivation Capital, who participated in previous rounds of funding. NarrativeDx will use the funds to accelerate sales and marketing, product innovation,
Read More
Emedgene Lands $6M to Expand AI-Driven Genomics Interpretation Platform
Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More
Konica Minolta Deploys AI Robots to Support Patient Care at Hospital in Italy
Konica Minolta announced a collaboration with the Casa Sollievo della Sofferenza Hospital in San Giovanni Rotondo, Foggia, Italy to better develop artificial intelligence (AI) in robots to assist in both urgent and non-urgent patient care. Specifically, the team wants to study the employment of robots to assist patients and support the work of nurses and doctors by conducting basic monitoring activities. The announcement follows the recent establishment of Konica Minolta’s latest research center
Read More
Why Artificial Intelligence Should Augment Patient Care, Not Replace IT
Skeptics about the future of artificial intelligence (AI) in healthcare are running out of reasons to be doubtful.AI, in fact, is already revolutionizing several areas of medicine. Researchers rely on AI to help them select candidates for clinical trials, algorithms are proving to be about as accurate as radiologists in diagnosing lung cancer, and experts from Oxford and Yale believe that all surgical work could be conducted by AI by the year 2053.Clearly, when it comes to clinical work, AI’s
Read More
VRHealth Launches First Telehealth VR Medical Platform
VRHealth, a Boston and Israel-based digital health company providing specialized virtual reality (VR) technology solutions and data analysis, today announced the launch of the first telehealth-VR medical platform that includes apps specifically designed for consumers to use at home. VR Health is participating in AARP Innovation Labs. As part of the company’s collaboration with AARP, VRhealth has a residency in AARP Innovation Lab and is integrating core features of its product into the “Health
Read More
Intelligent Health Monitoring Platform Myia Raises $6.75M to Improve Patients Lives Using Apple Watch, Fitbit, Motiv Ring
Intelligent health monitoring platform Myia Labs Inc. today announced it has raised $6.75M in seed funding led by applied artificial intelligence investors BootstrapLabs and Zetta Venture Partners with participation from the American College of Cardiology and The Boston Consulting Group. Myia harnesses the power of market wearables such as Apple Watch, Fitbit and Motiv’s Ring to monitor chronically ill patients and predict relapses before they happen. According to the American College of
Read More